Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 Feb;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018 Apr;50(2):303–316.
   PubMed Web of Science ®Google Scholar
• O’Keeffe LM, Taylor G. Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis. BMJ open. 2018 Oct 3;8(10):e021611.
   PubMed Web of Science ®Google Scholar
• Stiles BM, Rahouma M, Hussein MK, et al. Never smokers with resected lung cancer: different demographics, similar survival. Eur J Cardiothorac Surg. 2018 Apr 1;53(4):842–848.
   PubMed Web of Science ®Google Scholar
• Suda K, Mitsudomi T. Racial differences in lung cancer genetics. J Thorac Oncol. 2015 Feb;10(2):230–231.
   PubMed Web of Science ®Google Scholar
• Kerr KM, Tsao MS, Nicholson AG, et al. Programmed death-ligand 1 immunohistochemistry in lung cancer: in what state is this art? J Thorac Oncol. 2015 Jul;10(7):985–989.
   PubMed Web of Science ®Google Scholar
• Fan Y, Che X, Hou K, et al. MiR-940 promotes the proliferation and migration of gastric cancer cells through up-regulation of programmed death ligand-1 expression. Exp Cell Res. 2018 Dec 15;373(1–2):180–187.
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Dong K, et al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal. 2015 Mar;27(3):443–452.
   PubMed Web of Science ®Google Scholar
• Dong J, Zhu D, Tang X, et al. Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer. PloS one. 2019;14(7):e0220306.
   PubMed Web of Science ®Google Scholar
• Li H, Xu Y, Wan B, et al. The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients. Transl Lung Cancer Res. 2019 Aug;8(4):429–449.
   PubMed Web of Science ®Google Scholar
• Yang H, Shi J, Lin D, et al. Prognostic value of PD-L1 expression in combination with CD8(+) TILs density in patients with surgically resected non-small cell lung cancer. Cancer Med. 2018 Jan;7(1):32–45.
   PubMed Web of Science ®Google Scholar
• Paydas S, Bağır E, Seydaoglu G, et al. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma. Ann Hematol. 2015 Sep;94(9):1545–1552.
   PubMed Web of Science ®Google Scholar
• Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2014 Jan;15(1):7–21.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015 Nov;21(11):1253–1261.
   PubMed Web of Science ®Google Scholar
• Ramilowski JA, Chi WY, Agrawal S, et al. Functional annotation of human long non-coding RNAs via molecular phenotyping. 2020 Jul;30(7):1060-1072.
   Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
   PubMedGoogle Scholar
• Deng J, Deng H, Liu C, et al. Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448/Bcl-2. Biomed Pharmacother. 2018 Feb;98:102–110.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shi F, Xia Y, et al. LncRNA OIP5-AS1 predicts poor prognosis and regulates cell proliferation and apoptosis in bladder cancer. J Cell Biochem. 2019;120:7499–7505.
   PubMed Web of Science ®Google Scholar
• Zou Y, Yao S, Chen X, et al. LncRNA OIP5-AS1 regulates radioresistance by targeting DYRK1A through miR-369-3p in colorectal cancer cells. Eur J Cell Biol. 2018 Jun;97(5):369–378.
   PubMed Web of Science ®Google Scholar
• Wang M, Sun X, Yang Y, et al. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p. Thorac Cancer. 2018 Aug;9(8):939–949.
   PubMed Web of Science ®Google Scholar
• Han Z, Zhang Y, Yang Q, et al. miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget. 2015 May 30;6(15):13149–13163.
   PubMedGoogle Scholar
• Grentzmann G, Ingram JA, Kelly PJ, et al. A dual-luciferase reporter system for studying recoding signals. RNA. 1998 Apr;4(4):479–486.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001 Dec;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Yang N, Chen J, Zhang H, et al. LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma. Cell Death Dis. 2017 Aug 10;8(8):e2975.
   PubMedGoogle Scholar
• Arunkumar G, Anand S, Raksha P, et al. LncRNA OIP5-AS1 is overexpressed in undifferentiated oral tumors and integrated analysis identifies as a downstream effector of stemness-associated transcription factors. Sci Rep. 2018 May 4;8(1):7018.
   PubMedGoogle Scholar
• Chang K, Qu Y, Dai B, et al. PD-L1 expression in Xp11.2 translocation renal cell carcinoma: indicator of tumor aggressiveness. Sci Rep. 2017 May 18;7(1):2074.
   PubMedGoogle Scholar
• Azarbarzin S, Hosseinpour-Feizi MA, Banan Khojasteh SM, et al. MicroRNA −383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1. Life Sci. 2021 Feb 15;267:118939.
   PubMed Web of Science ®Google Scholar
• Cui Y, Yang X, Zhang X. Shrimp miR-34 from shrimp stress response to virus infection suppresses tumorigenesis of breast cancer. Mol Ther Nucleic Acids. 2017 Dec 15;9:387–398.
   PubMedGoogle Scholar
• Ji Q, Hao X, Meng Y, et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 2008 Sep 21;8(1):266.
   PubMedGoogle Scholar
• Shen D, Li J, Tao K, et al. Long non-coding RNA MCM3AP antisense RNA 1 promotes non-small cell lung cancer progression through targeting microRNA-195-5p. Bioengineered. 2021 Aug;12(1):3525–3538.
   PubMed Web of Science ®Google Scholar
• Feng J, Li J, Qie P, et al. [Long non-coding RNA (lncRNA) PGM5P4-AS1 inhibits lung cancer progression by up-regulating leucine zipper tumor suppressor (LZTS3) through sponging microRNA miR-1275]. Bioengineered. 2021 Dec;12(1):196–207.
   PubMed Web of Science ®Google Scholar
• Ma Y, Bao-Han W, Lv X, et al. MicroRNA-34a mediates the autocrine signaling of PAR2-activating proteinase and its role in colonic cancer cell proliferation. PloS one. 2013;8(8):e72383.
   PubMed Web of Science ®Google Scholar
• Kim JS, Kim EJ, Lee S, et al. MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas. Exp Mol Med. 2019 Jan 17;51(1):1–10.
   Google Scholar
• Qu F, Ye J, Pan X, et al. MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma. J Drug Target. 2019 Jan;27(1):67–74.
   PubMed Web of Science ®Google Scholar
• Wang F, Gu T, Chen Y, et al. Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis. Bioengineered. 2021 Sep;12(1):6724–6737.
   PubMed Web of Science ®Google Scholar